Can you use AI in a Canadian clinic without breaking PHIPA?

Yes, but only for certain tasks, and only with the right tool underneath. A Canadian clinic can use AI for scheduling notes, patient letters, and research summaries without touching Ontario's health privacy law, called PHIPA, in a risky way. The line gets drawn the moment a patient's name, diagnosis, or chart data enters the tool. That's where most clinics get this wrong, and it's an easy fix.

What does PHIPA actually restrict?

PHIPA, Ontario's Personal Health Information Protection Act, governs how clinics collect, use, and share identifiable health information. It doesn't ban AI. It doesn't ban US software outright, either. What it requires is that patient data stay protected, that you know where it goes, and that you can explain your safeguards if Ontario's privacy commissioner ever asks.

The risk isn't AI itself. The risk is feeding identifiable patient data into a tool that stores it on servers you don't control, run by a company that can't tell you who has access. Most consumer chatbots fall into that category. They weren't built for clinics, and their terms of service usually say so in the fine print.

Quebec clinics face a parallel rule under Law 25, the province's private-sector privacy law. It applies more broadly than PHIPA but the practical test is similar: know where the data goes, get consent for what you're doing with it, and don't hand it to a tool that can't account for itself.

Which clinic tasks are safe with AI right now?

Some tasks carry almost no privacy risk. Others need a tool built for healthcare from the ground up.

• Low risk, safe with almost any Canadian AI tool: drafting patient education handouts, summarizing published clinical guidelines, writing generic appointment reminder templates, researching billing codes.
• Medium risk, needs a compliant tool with a signed agreement: transcribing intake forms, drafting chart notes from dictation, triaging patient emails that mention symptoms.
• High risk, needs explicit safeguards and probably a specialist tool: summarizing full patient charts, flagging drug interactions from a medication list, anything that touches a diagnosis tied to a name.

The pattern is simple. The less identifiable the data, the more freedom you have. Once a real patient's information enters the prompt, you need to know the tool's data residency, its retention policy, and whether it trains its models on what you type in.

Why does it matter where the AI runs?

Because PHIPA and Law 25 both care about who can access patient data, and geography changes the answer.

A US-based AI company can, in principle, be compelled to hand over data to US authorities under laws like the CLOUD Act, because the company itself sits under US law. A Canadian AI platform with no US parent and no US investors doesn't carry that exposure for the customer content it holds. That's a meaningful difference for a clinic handling health records, not a technicality.

This is where "Canadian AI" means something concrete, not a marketing label. It means the company operates under Canadian law, stores customer data in Canada, and answers to Canadian regulators first. For a clinic owner who has never read a privacy statute and doesn't plan to start now, that's the shortcut worth remembering: pick the Canadian platform, and a chunk of the compliance question answers itself.

Augure is one example. It's a Canadian company with no US corporate parent and no US investors. Customer data is stored in Canada, as Canadian privacy rules require. Inference — the actual AI processing — runs on Canadian infrastructure or with vetted EU partners under strict no-retention agreements, and is never routed to US providers; some model tiers run in Canada by default, others in the EU, with the EU also covering failover. Two things do touch US systems: payment card processing and email delivery, both documented in the privacy policy. Customer conversations and documents are never used to train Augure's models. Augure Legal, a separate product built for law firms, does contract and compliance review under the same residency rules.

What does this cost a small clinic?

Less than most owners expect, and the free tier is a real option for low-risk tasks.

Augure's free plan gives you 50 messages a day and handles five documents, enough for drafting handouts or summarizing guidelines at no cost. The Pro tier, at C$20 a month, removes the message cap and adds persistent memory, useful if you want the tool to remember your clinic's templates and preferred tone across sessions. A busier clinic doing more document work might land on the Max tier at C$80 a month, which includes deep research agents and handles uploads up to 100MB.

None of these tiers make you PHIPA-compliant automatically. No AI vendor can promise that, and you should be skeptical of anyone who does. A Canadian AI platform gives you the infrastructure piece: data residency, no US legal exposure on customer content, no training on your inputs. The rest — consent forms, staff training, a written policy on what goes into the tool — is still on you.

If a patient's name and diagnosis are both in the prompt, you need a signed data agreement, not a free chatbot.

Do I need a privacy officer for this?

Not necessarily a dedicated hire, but someone needs to own the decision.

PHIPA already requires a designated contact for privacy questions at most clinics, often the office manager or a physician-owner. That same person should decide which tasks are AI-safe and which aren't, write it down in one page, and tell staff. This isn't a legal document. It's a checklist: what can go into the AI tool, what can't, and who to ask when it's unclear.

Clinics with more than a few practitioners often benefit from a short written AI policy, reviewed once a year. It doesn't need a lawyer to draft the first version. It needs someone to actually use the tools for a month, notice where staff get tempted to paste in a full chart note, and close that gap before it becomes a habit.

What to do this week

1. List every task where staff currently use AI or might soon, and mark each one low, medium, or high risk based on whether identifiable patient data touches it.
2. Check your current AI tool's data residency and training policy. If you can't find a straight answer in under five minutes, that's the answer.
3. Move medium and high-risk tasks to a Canadian AI platform with a signed data agreement, and leave the low-risk tasks on whatever tool is already working.

Augure starts free and scales from there, with Canadian storage and no US corporate parent standing between your clinic and your patients' data. Take a look at augureai.ca.

Where this comes from: Ontario's Personal Health Information Protection Act (PHIPA) and Quebec's Act respecting the protection of personal information in the private sector (Law 25) both govern the scenarios above.